Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

NCT03150693 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

310

Enrollment

OTHER

Sponsor class

Conditions

B Acute Lymphoblastic Leukemia

Interventions

DRUG: Allopurinol
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Vincristine Sulfate
DRUG: Dexamethasone
DRUG: Pegylated L-Asparaginase
DRUG: Methotrexate
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Mercaptopurine
BIOLOGICAL: Rituximab
DRUG: Doxorubicin
DRUG: Thioguanine
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]